Excretion of mutagens following chemotherapy.
The mutagenic activity of urine was evaluated in children receiving single and multiple agent chemotherapy to determine the duration of carcinogenic risk to health care personnel and family contacts. Urine samples from 21 children were evaluated before and daily for 5 days after chemotherapy administration. Mutagenic activity, a sensitive though not specific indicator of carcinogenic risk, was assayed using mutant strains of Salmonella typhimurium (the "Ames test"). Validity of the assay was confirmed by demonstrating mutagenic activity in urine samples from 17 adult cigarette smokers but not from 21 adult nonsmokers (24/24 versus 0/37, p less than 0.001). None of the 21 children tested demonstrated mutagenic activity before chemotherapy administration. Following single agent dactinomycin, cyclophosphamide, daunorubicin, doxorubicin, methotrexate, or vincristine, mutagenic activity was demonstrated for 2 days (5/5 at 1 and 2 days and 0/5 at 3 days). Following multiple agent chemotherapy using two or three of the latter drugs on a single day, mutagenic activity was demonstrated for 4 or 5 days (16/16 at 1, 2, 3, and 4 days, and 4/16 at 5 days). Based on these observations with urine, and presumably other body fluids, precautions are recommended for 2 days following single agent and at least 5 days following multiple agent chemotherapy.
Maniar
A C
AC
Cadham Provincial Laboratory, Winnipeg, Manitoba, Canada.
Williams
T W
TW
Hammond
G W
GW
Johnson
N
N
Kobrinsky
N L
NL
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002273:Carcinogens; D002648:Child; D006801:Humans; D009152:Mutagenicity Tests / Q000379:methods; D009153:Mutagens / Q000652:urine*; D009369:Neoplasms / Q000188:drug therapy / Q000652:urine; D012486:Salmonella typhimurium; D012907:Smoking / Q000652:urine
D000970:Antineoplastic Agents; D002273:Carcinogens; D009153:Mutagens